comparemela.com
Home
Live Updates
AOBiome announces the publication of positive Phase 2b results in The Lancets eClinicalMedicine for B244 in the treatment of mild-to-moderate atopic dermatitis and moderate-to-severe pruritus : comparemela.com
AOBiome announces the publication of positive Phase 2b results in The Lancet's eClinicalMedicine for B244 in the treatment of mild-to-moderate atopic dermatitis and moderate-to-severe pruritus
The peer-reviewed publication describes the significant effects of B244 in 4 weeks across key endpoints in adult patients with atopic dermatitis and associated...
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Todd Krueger ,
Jim Hoffman ,
Jonathan Silverberg ,
Clinical Research Organization ,
Health Sciences ,
Company Phase ,
George Washington University School Of Medicine ,
Aobiome Therapeutics Inc ,
Clinical Research ,
Worst Itch Numeric Rating Score ,
George Washington University School ,
Media Inquiries ,
Aobiome ,
comparemela.com © 2020. All Rights Reserved.